Stockreport

Zura Bio Announces Participation at February Investor Conferences

Zura Bio Limited - Class A Ordinary shares  (ZURA) 
PDF HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a multi-asset clinical-stage biotechnology company focused on developing novel medici [Read more]